Stock listing
Biomea Fusion, Inc.
Selected listing: BMEA · NASDAQ · USD · US
Biomea Fusion, Inc. (NASDAQ:BMEA), Health Technology. Latest release Sep 23, 2026: Biomea Fusion Announces Termination of Proposed Public Offering of Securities
- Ticker
- NASDAQ:BMEA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Biomea Fusion, Inc.
Biomea Fusion, Inc. is a public company traded under the ticker BMEA on the American market. Biomea Fusion focuses on developing innovative therapies for cancer treatment.
Latest news from Biomea Fusion, Inc.
Biomea Fusion Announces Termination of Proposed Public Offering of Securities
September 23, 2026
Biomea Fusion to Participate in Upcoming Investor Conferences
September 3, 2026
Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
August 24, 2026
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
August 13, 2026
Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 5, 2026